ERGO

Entia Biosciences Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 9/20/2016
Contact Info
  • 13565 SW Tualatin
  • Sherwood Rd #800
  • Sherwood, OR 97140

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001408299
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2833 - Medicinal and botanicals
Incorporated In: NV, USA
Year of Inc. 2007
Employees Not Available
Company Officers/Contacts
Marvin S. Hausman, M.D. Chief Scientific Officer
Carl J. Johnson President, CEO
Timothy A. Timmins EVP, COO, CFO
Company Directors
Marvin S. Hausman, M.D. Chairman
Carl J. Johnson
Elliot L. Shelton
Company Notes
  • Formerly=Total Nutraceutical Solutions until 2-2012
  • Formerly=Generic Marketing Services, Inc. until 10-2008
Service Providers
Accounting/Auditing Firm
Peterson Sullivan LLP
601 Union St.
Suite 2300
Seattle, WA, 98101
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available
ERGO Security Details
Share Structure
Market Value1 $2,533,137 a/o Dec 09, 2016
Authorized Shares 150,000,000 a/o Sep 20, 2016
Outstanding Shares 28,145,962 a/o Nov 14, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 10,282,719 a/o Jun 30, 2016
Par Value 0.001
Transfer Agent(s)
Empire Stock Transfer Inc.
Shareholders
Shareholders of Record 214 a/o Jun 30, 2016
Short Selling Data
Short Interest 1,500 (100%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security